at://
/
app.bsky.feed.post
/
3mnzf5g4s5r2i
sign in
All
4
Record
2
Post
1
PostEmbed
1
Post
by @danabra.mov
PostEmbed
by @danabra.mov
Record
by @jimpick.com
Record
by @atsui.org
+ new component
Post
Among adults with refractory #HidradenitisSuppurativa, golimumab led to durable improvement in disease severity; most responders used doses of 200–300 mg every 3–4 weeks. ja.ma/4ehcBKq
5d
JAMA Dermatology
